Clinical development costs are still rising, there is a decreasing success rate for new drug candidate approval and the duration of development is increasing.
Pharmaceutical companies are re-evaluating their
strategies to revolutionize R&D in order to make more
effective and informed go/no-go decisions, as early as
possible in the drug development process to reduce
attrition rates, and shorten drug development timescales.
Our delegates will be looking for advice, guidance and direction and this could be your opportunity to demonstrate the research services that you provide.